Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Fugger

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
The Lancet. Neurology|February 19, 2022
MOG antibody-associated disease after vaccination with ChAdOx1 nCoV-19Anna Francis, Jacqueline Palace, Lars Fugger
Brain : a Journal of Neurology|June 27, 2012
Natural killer cells and their receptors in multiple sclerosisGurman Kaur, John Trowsdale, Lars Fugger
Cell|April 4, 2020
Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune DiseasesLars Fugger, Lise Torp Jensen, Jamie Rossjohn
The New England Journal of Medicine|December 21, 2012
Genomewide association studies and common disease--realizing clinical utilityLars Fugger, Gil McVean, John I Bell
Nature Reviews. Neurology|November 19, 2016
Neuroinflammation - using big data to inform clinical practiceCalliope A Dendrou, Gil McVean, Lars Fugger
Nature Reviews. Neurology|March 19, 2014
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosisManuel A Friese, Benjamin Schattling, Lars Fugger
Brain : a Journal of Neurology|August 14, 2025
T cells turn in Alzheimer's diseaseDonal Skelly, Kathrine E Attfield, Lars Fugger
Nature Reviews. Immunology|August 8, 2015
Immunopathology of multiple sclerosisCalliope A Dendrou, Lars Fugger, Manuel A Friese
Pharmacogenomics|September 13, 2013
A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosisCalliope A Dendrou, John I Bell, Lars Fugger
Immunological Reviews|June 26, 2012
Bridging the gap from genetic association to functional understanding: the next generation of mouse models of multiple sclerosisKathrine E Attfield, Calliope A Dendrou, Lars Fugger
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
The Lancet. Neurology|February 19, 2022
MOG antibody-associated disease after vaccination with ChAdOx1 nCoV-19Anna Francis, Jacqueline Palace, Lars Fugger
Brain : a Journal of Neurology|June 27, 2012
Natural killer cells and their receptors in multiple sclerosisGurman Kaur, John Trowsdale, Lars Fugger
Cell|April 4, 2020
Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune DiseasesLars Fugger, Lise Torp Jensen, Jamie Rossjohn
The New England Journal of Medicine|December 21, 2012
Genomewide association studies and common disease--realizing clinical utilityLars Fugger, Gil McVean, John I Bell
Nature Reviews. Neurology|November 19, 2016
Neuroinflammation - using big data to inform clinical practiceCalliope A Dendrou, Gil McVean, Lars Fugger
Nature Reviews. Neurology|March 19, 2014
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosisManuel A Friese, Benjamin Schattling, Lars Fugger
Brain : a Journal of Neurology|August 14, 2025
T cells turn in Alzheimer's diseaseDonal Skelly, Kathrine E Attfield, Lars Fugger
Nature Reviews. Immunology|August 8, 2015
Immunopathology of multiple sclerosisCalliope A Dendrou, Lars Fugger, Manuel A Friese
Pharmacogenomics|September 13, 2013
A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosisCalliope A Dendrou, John I Bell, Lars Fugger
Immunological Reviews|June 26, 2012
Bridging the gap from genetic association to functional understanding: the next generation of mouse models of multiple sclerosisKathrine E Attfield, Calliope A Dendrou, Lars Fugger
Pageof 12